Our Dossier Support Includes
End-to-end preparation of scientifically structured, GMP-compliant, and regulatory submission-ready technical dossiers covering formulation development, analytical validation, stability studies, process validation, technology transfer, and global compliance documentation for seamless product approval and commercialisation.
Product Development Dossier Preparation
- Comprehensive development traceability: Complete compilation of formulation development history, composition rationale, optimisation studies, analytical findings establishing product evolution.
- Scientific justification documentation: Stability data integration with scientifically structured rationale supporting formulation choices throughout the development lifecycle.
- End-to-end development records: From initial feasibility through scale-up, capturing all critical development milestones for regulatory submission.
- Regulatory submission alignment: Documentation structured to support DMF, CTD, and ACTD requirements, facilitating seamless authority review and approval.
Technical Data Package Preparation
- Detailed manufacturing specifications: Preparation covering raw material specs, finished product specifications, process flow diagrams with manufacturing protocols.
- Critical parameter documentation: Comprehensive capture of Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) throughout production.
- Equipment and process detailing: Complete equipment specifications, operational parameters, and validation requirements for manufacturing reproducibility.
- Quality control integration: In-process controls, sampling procedures, and acceptance criteria aligned with pharmaceutical quality management systems.
Master Formula Record (MFR) Support
- GMP-compliant formula documentation: Development of validated batch formulas with precise process instructions and equipment details throughout the manufacturing sequence.
- In-process control checkpoints: Integration of critical manufacturing checkpoints ensuring batch-to-batch consistency and quality assurance.
- Equipment qualification linkage: Master records connected to qualified equipment documentation supporting validation and inspection readiness.
- Scalability documentation support: MFR structured for pilot-to-commercial scale transition, maintaining formulation integrity and reproducibility.
Analytical Method Dossier Support
- Validated analytical methodology: Compilation of validated methods, including assay, dissolution profiling, and encapsulation efficiency across all test parameters.
- Advanced characterisation techniques: Particle size analysis, zeta potential, polydispersity index, microbial limits documented with validation data.
- Stability-indicating parameters: Method validation demonstrating specificity for degradation products supporting shelf-life claims and storage conditions.
- Regulatory method alignment: All analytical procedures are aligned with ICH Q2(R1) guidelines, ensuring international submission acceptance.
Stability Study Dossier Preparation
- ICH-compliant stability protocols: Documentation of accelerated, intermediate, and long-term stability studies following international regulatory guidance.
- Real-time data interpretation: Comprehensive analysis of stability trends with statistical evaluation supporting shelf-life justification.
- Storage condition validation: Testing across multiple temperature/humidity conditions, establishing optimal storage and distribution parameters.
- Degradation pathway documentation: Identification and quantification of degradation products supporting product quality throughout shelf life.
Regulatory Submission Documentation Support
- Multi-jurisdictional submission readiness: Preparation of submission-ready dossiers aligned with pharmaceutical, nutraceutical, FSSAI, and CDSCO requirements.
- DMF / CTD / ACTD formatting: Structured documentation following Drug Master File, Common Technical Document, ASEAN submission formats.
- Authority-specific customisation: Tailored documentation addressing jurisdiction-specific requirements for FDA, EMA, MHRA, GCC submissions.
- Accelerated approval pathways: Strategic dossier organisation facilitates faster regulatory review and deficiency response management.
Specification & COA Documentation Support
- Scientifically justified specifications: Development of acceptance criteria, test methods, and release standards for raw materials and finished products.
- Certificate of Analysis formatting: Standardised COA templates with compendial test method references and pharmacopeial compliance traceability.
- Statistical acceptance criteria: Data-driven specification limits based on process capability studies and quality risk management.
- Vendor qualification integration: Raw material specifications linked to approved vendor qualification dossiers supporting supply chain compliance.
Process Validation Dossier Support
- Three-batch validation protocols: Preparation covering process reproducibility, batch consistency, and in-process controls for commercial manufacturing assurance.
- GMP-compliant validation reports: Comprehensive documentation demonstrating process capability and product quality consistency across production batches.
- Equipment qualification linkage: Validation protocols connected to IQ/OQ/PQ documentation supporting holistic manufacturing validation.
- Continuous process verification: Post-validation monitoring protocols ensuring ongoing process control and regulatory compliance maintenance.
Technology Transfer Dossier Support
- Complete transfer package compilation: Scale-up parameters, process transfer protocols, and equipment recommendations for receiving site implementation.
- Troubleshooting strategy documentation: Comprehensive guidance on potential issues, corrective actions, and optimisation opportunities during transfer.
- Commercial execution guidance: Detailed instructions supporting seamless pilot-to-commercial transition, maintaining product quality and regulatory compliance.
- Site-specific customisation support: Adaptation of process parameters to receiving facility capabilities while maintaining formulation integrity.
Analytical Testing & Particle Size Distribution
- Nanometer-range vesicle validation: Detailed PSD reports using laser diffraction and dynamic light scattering documenting precise particle control.
- Transparency correlation data: Empirical proof that particles remain small enough to avoid light scattering, ensuring a crystal-clear visual profile.
- Homogeneity documentation: Reports proving uniform liposome distribution throughout formulation, preventing aggregation and phase separation.
- Batch-to-batch consistency: Statistical analysis demonstrating reproducible particle size across manufacturing runs supporting quality claims.
Microscopic Visual Verification & Structural Confirmation
- High-resolution microscopic analysis: Electron microscopy and phase-contrast imaging providing direct visualisation of liposomal vesicle structure.
- Unilamellar vesicle confirmation: Morphological verification proving formation of single-layered spheres, ensuring optimal encapsulation efficiency.
- Encapsulation visual proof: Physical evidence that highly purified saturated phospholipids successfully encapsulated actives without empty vesicles.
- Raw ingredient exclusion verification: Confirmation that no free crystalline active ingredients exist in suspension, validating complete encapsulation.
Franz Diffusion Cell Studies – Sustained Release Profiling
- In-vitro permeation testing documentation: Comparative data demonstrating liposomal active behaviour over 24 hours versus conventional formulations.
- Flux and permeation curves: Quantitative proof of deep penetration using scientifically validated diffusion methodology supporting efficacy claims.
- Controlled release profiling: Evidence of sustained therapeutic levels within epidermis and dermis significantly longer than standard solutions.
- Dermal retention quantification: Documentation proving active concentration in target skin layers, validating the topical delivery mechanism.
Stability & Shelf-Life Acceleration Data
- Accelerated stability testing protocols: Products subjected to controlled stress, including high heat, humidity, and light exposure, to validate formulation robustness.
- pH and viscosity mapping: Documentation of stability over time proving proprietary stabilisation prevents precipitation or formula failure.
- Organoleptic integrity preservation: Data confirming premium stable lipids maintain aesthetic and chemical profile throughout shelf life.
- Long-term storage validation: Real-time stability data supporting shelf-life claims and storage condition recommendations for commercial distribution.
Safety & Toxicological Assessment
- Dermal retention safety data: Documentation showing specific active concentration within skin layers versus negligible systemic absorption amounts.
- Local-first delivery validation: Technical justifications and modelling data supporting minimal systemic absorption claim for topical formulations.
- Irritation and sensitisation profiles: Safety assessments highlighting the low-irritation potential of bio-compatible, purified phospholipids without ethanol.
- High-potency acid compatibility: Evidence that even aggressive actives maintain a safety profile through liposomal encapsulation technology.
Full Ingredient Transparency & Compliance
- Complete regulatory documentation: Technical Data Sheets (TDS), Material Safety Data Sheets (MSDS), Certificate of Analysis (COA) for submissions.
- INCI compliance verification: alignment with the International Nomenclature of Cosmetic Ingredients to support global cosmetic regulatory requirements.
- Pharmacopeial traceability: All raw materials linked to USP, EP, BP, or IP monographs, ensuring compendial compliance.
- Regulatory breakdown for markets: Structured technical files facilitate registration in pharmaceutical, nutraceutical, and cosmeceutical markets globally.
Product-Specific Documentation Includes
Pharmaceutical, nutraceutical, cosmeceutical applications with sector-specific regulatory documentation and compliance requirements.
DMF, CTD, ACTD, FSSAI, CDSCO formats tailored to target markets with jurisdiction-specific technical packages.
From development through commercialisation, including post-approval changes and annual product reviews.
End-to-end guidance on dossier requirements, authority expectations, and deficiency response strategies.
Documentation Troubleshooting
Out-of-spec results, acceptance criteria, and retesting strategies clarified
Process deviations, method validation, and reproducibility issues corrected
Degradation pathways, storage conditions, and shelf-life justifications revalidated
Technical gaps, clarification requests, and additional data requirements addressed
Formula-process alignment, scale-up discrepancies, and CPP/CQA linkages resolved
Dossier Preparation & Submission Readiness
Selection of appropriate documentation framework (DMF, CTD, ACTD, FSSAI, CDSCO) based on target market and regulatory pathway strategy.
Comprehensive compilation using validated templates, standardised formats, and authority-specific requirements, ensuring accuracy, completeness, and regulatory alignment.
Complete evaluation of analytical data, stability results, manufacturing records, and quality documentation ensuring consistency across dossier sections.
Structured submission packages including cover letters, administrative documentation, technical justifications, and response templates suitable for authority review.
Why Partner with Lipoedge for Dossier Support
Integrated dossier preparation from formulation development through regulatory submission, ensuring seamless alignment across all technical sections.
Comprehensive experience with FSSAI, CDSCO, DMF, CTD, ACTD, FDA, EMand A, and MHRA requirements conducted under one roof.
Documentation designed using pharmaceutical standards, ICH guidelines, and validated methodologies supporting regulatory approval success.
Tailored dossier strategies, jurisdiction-specific formats, and sector-adapted documentation based on product type and target market.
Driven by highly qualified regulatory professionals with decades of submission experience, ensuring accuracy, compliance, and successful approvals.
Ready to Elevate Your
Formulation Testing?
Partner with LipoEdge's expert scientific team for end-to-end in vitro analytical support — from study design to regulatory submission.
Frequently Asked Questions
In vitro chemical testing generates release, stability, and bioaccessibility data, enabling informed formulation decisions across nutraceutical, pharmaceutical, and cosmeceutical product development pipelines. This reduces development uncertainty, supports faster optimisation of dosage forms, and strengthens technical confidence before scale-up, validation, and regulatory submission stages.
The INFOGEST model simulates human digestion conditions across salivary, gastric, and intestinal phases, enabling realistic evaluation of liposomal stability and release behaviour. It helps predict oral bioavailability, validate formulation performance under physiological conditions, and support scientifically substantiated claims for product positioning and regulatory documentation.
Dialysis and simulated digestion studies quantify controlled release behaviour, enabling clear differentiation between liposomal systems and conventional formulations in performance-driven markets. This supports claims of sustained delivery, improved absorption, and enhanced functionality, strengthening product positioning across competitive nutraceutical and pharmaceutical segments globally.
LipoEdge provides integrated in vitro testing using validated digestion models, diffusion systems, and antioxidant assays to ensure reliable and reproducible analytical outcomes. It enables clients to generate regulatory-aligned data, optimise formulations effectively, and accelerate product development timelines with strong technical and commercial confidence.
LipoEdge combines formulation understanding with analytical expertise, enabling customised study designs tailored to liposomal, nanosomal, and encapsulated delivery systems across applications. This ensures deeper insight into product behaviour, improved interpretation of results, and stronger alignment between laboratory findings and real-world product performance expectations.